Latest filing published 01 Aug 2023 for Spectrum Pharmaceuticals INC. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Keith M. McGahan is a declared insider of Spectrum Pharmaceuticals Inc (senior executive), with filings sourced from SEC (Form 4). Between 13 May 2021 and 31 July 2023, the trades on record add up to 10 filings.
On the market, this insider has only sold: 7 sales, €66k in total. Outside the open market, there are 2 share grants. 2023 to date brings no purchases and 3 sales.
The newest entry dates from 1 August 2023: a transaction, in Spectrum Pharmaceuticals Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations